Compare Stocks: LFMD, TDOC, AMWL, NVO, LLY, and LH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMWL American Well	$11.84 +0.4%	$10.67	$3.71 ▼ $14.19	$196.97M	1.68	118,930 shs	56,375 shs
LFMD LifeMD	$3.31 +0.9%	$4.10	$2.56 ▼ $7.32	$159.55M	2.02	1.09 million shs	406,169 shs
LH Labcorp	$336.03 +1.0%	$292.52	$244.52 ▼ $338.19	$27.28B	0.87	703,494 shs	792,662 shs
LLY Eli Lilly and Company	$1,257.26 +1.0%	$1,180.14	$694.23 ▼ $1,292.65	$1.18T	0.51	2.83 million shs	2.50 million shs
NVO Novo Nordisk A/S	$46.81 +1.5%	$47.69	$35.12 ▼ $64.16	$208.69B	0.76	14.23 million shs	10.89 million shs
TDOC Teladoc Health	$6.41 -1.2%	$8.08	$4.40 ▼ $9.89	$1.16B	2.12	5.88 million shs	3.47 million shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMWL American Well	0.00%	-5.06%	+10.64%	+48.24%	+72.34%
LFMD LifeMD	0.00%	-4.06%	-14.47%	-21.00%	-46.53%
LH Labcorp	0.00%	+5.66%	+15.68%	+29.06%	+20.89%
LLY Eli Lilly and Company	0.00%	+6.35%	+6.07%	+17.88%	+78.40%
NVO Novo Nordisk A/S	0.00%	+1.96%	-2.84%	+4.23%	-13.79%
TDOC Teladoc Health	0.00%	-6.07%	-26.18%	-2.66%	-11.16%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMWL American Well	$11.84 +0.4%	$10.67	$3.71 ▼ $14.19	$196.97M	1.68	118,930 shs	56,375 shs
LFMD LifeMD	$3.31 +0.9%	$4.10	$2.56 ▼ $7.32	$159.55M	2.02	1.09 million shs	406,169 shs
LH Labcorp	$336.03 +1.0%	$292.52	$244.52 ▼ $338.19	$27.28B	0.87	703,494 shs	792,662 shs
LLY Eli Lilly and Company	$1,257.26 +1.0%	$1,180.14	$694.23 ▼ $1,292.65	$1.18T	0.51	2.83 million shs	2.50 million shs
NVO Novo Nordisk A/S	$46.81 +1.5%	$47.69	$35.12 ▼ $64.16	$208.69B	0.76	14.23 million shs	10.89 million shs
TDOC Teladoc Health	$6.41 -1.2%	$8.08	$4.40 ▼ $9.89	$1.16B	2.12	5.88 million shs	3.47 million shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMWL American Well	0.00%	-5.06%	+10.64%	+48.24%	+72.34%
LFMD LifeMD	0.00%	-4.06%	-14.47%	-21.00%	-46.53%
LH Labcorp	0.00%	+5.66%	+15.68%	+29.06%	+20.89%
LLY Eli Lilly and Company	0.00%	+6.35%	+6.07%	+17.88%	+78.40%
NVO Novo Nordisk A/S	0.00%	+1.96%	-2.84%	+4.23%	-13.79%
TDOC Teladoc Health	0.00%	-6.07%	-26.18%	-2.66%	-11.16%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMWL American Well	2.00	Hold	$9.50	-19.76% Downside
LFMD LifeMD	2.70	Moderate Buy	$7.57	128.74% Upside
LH Labcorp	2.75	Moderate Buy	$330.00	-1.79% Downside
LLY Eli Lilly and Company	2.83	Moderate Buy	$1,292.18	2.78% Upside
NVO Novo Nordisk A/S	2.21	Hold	$64.94	38.73% Upside
TDOC Teladoc Health	2.25	Hold	$7.54	17.56% Upside

Current Analyst Ratings Breakdown

Latest LFMD, TDOC, AMWL, NVO, LLY, and LH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/19/2026	TDOC Teladoc Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/17/2026	LFMD LifeMD	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/13/2026	AMWL American Well	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Hold	$7.50 ➝ $12.00
8/12/2026	NVO Novo Nordisk A/S	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$47.00
8/12/2026	NVO Novo Nordisk A/S	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold
8/11/2026	LLY Eli Lilly and Company	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy (B) ➝ Buy (B-)
8/11/2026	NVO Novo Nordisk A/S	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/10/2026	LH Labcorp	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$355.00
8/7/2026	LFMD LifeMD	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Overweight	$5.00
8/7/2026	LLY Eli Lilly and Company	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$1,376.00
8/7/2026	LFMD LifeMD	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$10.00 ➝ $9.00

(Data available from 8/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMWL American Well	$249.32M	0.79	N/A	N/A	$14.16 per share	0.84
LFMD LifeMD	$194.05M	0.82	N/A	N/A	$0.17 per share	19.47
LH Labcorp	$14.35B	1.90	$24.80 per share	13.55	$106.13 per share	3.17
LLY Eli Lilly and Company	$65.18B	18.16	$25.18 per share	49.94	$35.99 per share	34.93
NVO Novo Nordisk A/S	$46.80B	4.47	$4.70 per share	9.97	$6.58 per share	7.11
TDOC Teladoc Health	$2.53B	0.46	$1.81 per share	3.55	$7.21 per share	0.89

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMWL American Well	-$95.70M	-$4.77	N/A	N/A	N/A	-35.75%	-30.12%	-22.30%	11/3/2026 (Estimated)
LFMD LifeMD	$14.35M	-$0.05	N/A	47.29	N/A	0.10%	-168.23%	-31.27%	N/A
LH Labcorp	$876.50M	$12.09	27.79	17.09	1.95	6.99%	16.74%	7.81%	10/27/2026 (Estimated)
LLY Eli Lilly and Company	$20.64B	$29.80	42.19	27.41	1.48	33.53%	97.83%	23.23%	10/29/2026 (Estimated)
NVO Novo Nordisk A/S	$15.51B	$4.09	11.44	13.89	4.23	35.36%	61.20%	21.49%	11/4/2026 (Estimated)
TDOC Teladoc Health	-$200.32M	-$0.99	N/A	N/A	N/A	-7.13%	-12.15%	-5.83%	10/28/2026 (Estimated)

Latest LFMD, TDOC, AMWL, NVO, LLY, and LH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q2 2026	LFMD LifeMD	-$0.1457	-$0.16	-$0.0143	-$0.16	$49.16 million	$47.28 million
8/5/2026	Q2 2026	LLY Eli Lilly and Company	$6.40	$8.38	+$1.98	$7.94	$20.82 billion	$22.97 billion
8/5/2026	Q2 2026	NVO Novo Nordisk A/S	$0.77	$0.96	+$0.19	$0.72	$10.89 billion	$11.98 billion
8/4/2026	Q2 2026	AMWL American Well	-$0.86	-$0.59	+$0.27	-$0.59	$49.87 million	$52.05 million
7/30/2026	Q2 2026	LH Labcorp	$4.78	$4.99	+$0.21	$3.64	$3.71 billion	$3.73 billion
7/29/2026	Q2 2026	TDOC Teladoc Health	-$0.2498	-$0.21	+$0.0398	-$0.21	$615.44 million	$606.93 million
6/30/2026	Q2 2026	NVO Novo Nordisk A/S	N/A	$0.9440	N/A	$0.72	N/A	$11.98 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMWL American Well	N/A	N/A	N/A	N/A	N/A
LFMD LifeMD	N/A	N/A	N/A	N/A	N/A
LH Labcorp	$2.88	0.86%	N/A	23.82%	N/A
LLY Eli Lilly and Company	$6.92	0.55%	+15.18%	23.22%	11 Years
NVO Novo Nordisk A/S	$0.82	1.75%	+21.74%	20.05%	N/A
TDOC Teladoc Health	N/A	N/A	N/A	N/A	N/A

Latest LFMD, TDOC, AMWL, NVO, LLY, and LH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/9/2026	LH Labcorp	quarterly	$0.72	1.04%	8/28/2026	8/28/2026	9/11/2026
6/22/2026	LLY Eli Lilly and Company	quarterly	$1.73	0.59%	8/14/2026	8/14/2026	9/10/2026
8/5/2026	NVO Novo Nordisk A/S		$0.5786	2.58%	8/17/2026	8/17/2026	8/25/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMWL American Well	N/A	2.90	2.89
LFMD LifeMD	N/A	0.90	0.84
LH Labcorp	0.69	1.80	1.53
LLY Eli Lilly and Company	1.41	1.35	1.00
NVO Novo Nordisk A/S	0.59	0.79	0.56
TDOC Teladoc Health	N/A	0.83	0.81

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMWL American Well	56.05%
LFMD LifeMD	35.52%
LH Labcorp	95.94%
LLY Eli Lilly and Company	82.53%
NVO Novo Nordisk A/S	11.54%
TDOC Teladoc Health	76.82%

Insider Ownership

Company	Insider Ownership
AMWL American Well	12.84%
LFMD LifeMD	17.22%
LH Labcorp	0.84%
LLY Eli Lilly and Company	0.14%
NVO Novo Nordisk A/S	0.07%
TDOC Teladoc Health	0.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMWL American Well	1,040	16.55 million	14.43 million	Optionable
LFMD LifeMD	230	48.20 million	39.90 million	Optionable
LH Labcorp	71,000	81.10 million	80.42 million	Optionable
LLY Eli Lilly and Company	50,000	941.36 million	940.04 million	Optionable
NVO Novo Nordisk A/S	69,505	4.47 billion	4.46 billion	Optionable
TDOC Teladoc Health	5,600	181.68 million	180.41 million	Optionable

LFMD, TDOC, AMWL, NVO, LLY, and LH Headlines

Recent News About These Companies

Zacks Research Predicts Reduced Earnings for Teladoc Health

August 23 at 1:13 AM | americanbankingnews.com

Analysts Offer Predictions for Teladoc Health Q3 Earnings

August 21 at 7:41 AM | marketbeat.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

August 20 at 10:00 AM | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Teladoc Health, Inc. – TDOC

August 18, 2026 | globenewswire.com

U.S. Mental Health Treatment Market Report 2026–2030: Evaluating $159 Billion Forecast, Digital App Adoption, and Strategies of Acadia Healthcare, UHS, Talkspace, and Elevance Health

August 17, 2026 | finance.yahoo.com

Monaco Asset Management SAM Takes $26.86 Million Position in Teladoc Health, Inc. $TDOC

August 17, 2026 | marketbeat.com

Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

August 17, 2026 | prnewswire.com

Teladoc Announces Upcoming Retirement of Longtime Board Director

August 13, 2026 | tipranks.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

August 13, 2026 | prnewswire.com

HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum

August 12, 2026 | finance.yahoo.com

Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity

August 12, 2026 | finance.yahoo.com

Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?

August 12, 2026 | finance.yahoo.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

August 11, 2026 | globenewswire.com

1 Internet Stock with Impressive Fundamentals and 2 We Question

August 9, 2026 | finance.yahoo.com

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

August 8, 2026 | fool.com

Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky

August 7, 2026 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

August 6, 2026 | prnewswire.com

Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced - Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

August 6, 2026 | tmcnet.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (TDOC) and Karyopharm Therapeutics (KPTI)

August 6, 2026 | theglobeandmail.com

Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

August 5, 2026 | businesswire.com

Teladoc Shares Plunged More Than 28% After Earnings. How to Play TDOC Here.

August 5, 2026 | barchart.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

LFMD, TDOC, AMWL, NVO, LLY, and LH Company Descriptions

American Well NYSE:AMWL

$11.84 +0.05 (+0.42%)

As of 08/21/2026 03:58 PM Eastern

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

LifeMD NASDAQ:LFMD

$3.31 +0.03 (+0.91%)

As of 08/21/2026 04:00 PM Eastern

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Labcorp NYSE:LH

$336.03 +3.22 (+0.97%)

As of 08/21/2026 03:58 PM Eastern

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Eli Lilly and Company NYSE:LLY

$1,257.26 +12.86 (+1.03%)

As of 08/21/2026 03:58 PM Eastern

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Novo Nordisk A/S NYSE:NVO

$46.81 +0.67 (+1.45%)

As of 08/21/2026 03:58 PM Eastern

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Teladoc Health NYSE:TDOC

$6.41 -0.08 (-1.23%)

As of 08/21/2026 03:58 PM Eastern

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LFMD, TDOC, AMWL, NVO, LLY, and LH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LFMD, TDOC, AMWL, NVO, LLY, and LH Earnings

Compare Dividends

Latest LFMD, TDOC, AMWL, NVO, LLY, and LH Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LFMD, TDOC, AMWL, NVO, LLY, and LH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

LFMD, TDOC, AMWL, NVO, LLY, and LH Company Descriptions

American Well NYSE:AMWL

LifeMD NASDAQ:LFMD

Labcorp NYSE:LH

Eli Lilly and Company NYSE:LLY

Novo Nordisk A/S NYSE:NVO

Teladoc Health NYSE:TDOC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools